Ellevest Inc’s Wave Life Sciences WVE Stock Holding History

Ellevest Inc’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32	Closed	–	–	1973
2022 Q3	$0	Hold	32	–	–	﹤0.01%	1885
2022 Q2	$0	Hold	32	–	–	﹤0.01%	1719
2022 Q1	$0	Buy	+32	New	+$78	﹤0.01%	1651

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ellevest Inc's WVE Position: Q4 2022 in Review

Ellevest Inc sold out of Wave Life Sciences (WVE) in Q4 2022, closing a stake of 32 shares.

Ellevest Inc first reported a position in WVE in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 75 funds tracked by Wall St. Rank hold WVE as of Q4 2022.

Ellevest Inc reported no remaining Wave Life Sciences position as of Q4 2022 after selling out during the quarter.
Ellevest Inc sold 32 Wave Life Sciences shares in Q4 2022.
Ellevest Inc first reported a position in Wave Life Sciences in Q1 2022 and held it in 3 quarters.
Ellevest Inc's Wave Life Sciences position peaked at $0 in Q3 2022.
75 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.